Cargando…
Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment
Non-small-cell lung cancer (NSCLC) remains one of the leading causes of death worldwide. While NSCLCs possess antigens that can potentially elicit T cell responses, defective tumor antigen presentation and T cell activation hinder host anti-tumor immune responses. The NSCLC tumor microenvironment (T...
Autores principales: | Abascal, Jensen, Oh, Michael S., Liclican, Elvira L., Dubinett, Steven M., Salehi-Rad, Ramin, Liu, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571973/ https://www.ncbi.nlm.nih.gov/pubmed/37830618 http://dx.doi.org/10.3390/cells12192404 |
Ejemplares similares
-
Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burden
por: Salehi-Rad, Ramin, et al.
Publicado: (2021) -
CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity
por: Salehi-Rad, Ramin, et al.
Publicado: (2023) -
Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment
por: Papadas, Athanasios, et al.
Publicado: (2022) -
Genotoxic Treatment Enhances Immune Response in a Genetic Model of Lung Cancer
por: Saggese, Pasquale, et al.
Publicado: (2021) -
Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
por: Fu, Chunmei, et al.
Publicado: (2018)